Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients

The results from our new, large cohort of European patients treated with ustekinumab in daily clinical practice confirm the role of HLA-C*06 as a potential predictor of response to ustekinumab.